These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2224428)

  • 1. Calcium oxalate crystallisation kinetics and the effects of calcium and gamma-carboxyglutamic acid.
    Nishio S; Kavanagh JP; Faragher EB; Garside J; Blacklock NJ
    Br J Urol; 1990 Oct; 66(4):351-6. PubMed ID: 2224428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased inhibitory activity of prothrombin to calcium oxalate crystallization by specific chemical modification of its gamma-carboxyglutamic acid residues.
    Liu J; Wang T; Chen J; Wang S; Ye Z
    Urology; 2006 Jan; 67(1):201-3. PubMed ID: 16413375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of protein-bound urinary gamma-carboxyglutamic acid in calcium nephrolithiasis.
    Colette C; Benmbarek A; Boniface H; Astre C; Pares-Herbute N; Monnier L; Guitter J
    Clin Chim Acta; 1991 Dec; 204(1-3):43-50. PubMed ID: 1819473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.
    Kavanagh JP; Nishio S; Garside J; Blacklock NJ
    J Urol; 1993 Mar; 149(3):614-7. PubMed ID: 8437278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio.
    Kavanagh JP; Jones L; Rao PN
    Urol Res; 1999 Aug; 27(4):231-7. PubMed ID: 10460891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.
    Kavanagh JP
    Scanning Microsc; 1992 Sep; 6(3):685-704; discussion 704-5. PubMed ID: 1439665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.
    Nakagawa Y; Abram V; Parks JH; Lau HS; Kawooya JK; Coe FL
    J Clin Invest; 1985 Oct; 76(4):1455-62. PubMed ID: 4056037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nidus, crystalluria and aggregation: key ingredients for stone enlargement.
    Saw NK; Rao PN; Kavanagh JP
    Urol Res; 2008 Feb; 36(1):11-5. PubMed ID: 18030459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
    Liu J; Chen J; Wang T; Wang S; Ye Z
    J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of human osteocalcins: gamma-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition.
    Nakao M; Nishiuchi Y; Nakata M; Kimura T; Sakakibara S
    Pept Res; 1994; 7(4):171-4. PubMed ID: 7696837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
    Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
    J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
    J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.
    Worcester EM; Sebastian JL; Hiatt JG; Beshensky AM; Sadowski JA
    Calcif Tissue Int; 1993 Oct; 53(4):242-8. PubMed ID: 8275352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals.
    Goiko M; Dierolf J; Gleberzon JS; Liao Y; Grohe B; Goldberg HA; de Bruyn JR; Hunter GK
    PLoS One; 2013; 8(11):e80344. PubMed ID: 24265810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.